First Mercantile Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,505
| Closed | -$68K | – | 915 |
|
|
2020
Q1 | $68K | Buy |
1,505
+67
| +5% | +$3.03K | 0.01% | 647 |
|
|
2019
Q4 | $94K | Sell |
1,438
-5
| -0.3% | -$327 | 0.01% | 699 |
|
|
2019
Q3 | $90K | Buy |
1,443
+151
| +12% | +$9.42K | 0.01% | 721 |
|
|
2019
Q2 | $92K | Buy |
1,292
+2
| +0.2% | +$142 | 0.01% | 663 |
|
|
2019
Q1 | $101K | Buy |
1,290
+144
| +13% | +$11.3K | 0.02% | 658 |
|
|
2018
Q4 | $97K | Buy |
1,146
+128
| +13% | +$10.8K | 0.02% | 663 |
|
|
2018
Q3 | $174K | Sell |
1,018
-329
| -24% | -$56.2K | 0.03% | 552 |
|
|
2018
Q2 | $174K | Hold |
1,347
| – | – | 0.03% | 548 |
|
|
2018
Q1 | $139K | Sell |
1,347
-3,504
| -72% | -$362K | 0.03% | 604 |
|
|
2017
Q4 | $414K | Buy |
4,851
+948
| +24% | +$80.9K | 0.08% | 311 |
|
|
2017
Q3 | $332K | Buy |
3,903
+1,803
| +86% | +$153K | 0.06% | 407 |
|
|
2017
Q2 | $159K | Buy |
2,100
+32
| +2% | +$2.42K | 0.03% | 618 |
|
|
2017
Q1 | $137K | Sell |
2,068
-144
| -7% | -$9.54K | 0.02% | 674 |
|
|
2016
Q4 | $140K | Buy |
2,212
+353
| +19% | +$22.3K | 0.02% | 672 |
|
|
2016
Q3 | $118K | Sell |
1,859
-369
| -17% | -$23.4K | 0.02% | 699 |
|
|
2016
Q2 | $166K | Sell |
2,228
-225
| -9% | -$16.8K | 0.02% | 643 |
|
|
2016
Q1 | $164K | Sell |
2,453
-224
| -8% | -$15K | 0.02% | 624 |
|
|
2015
Q4 | $181K | Sell |
2,677
-545
| -17% | -$36.8K | 0.02% | 668 |
|
|
2015
Q3 | $172K | Buy |
3,222
+561
| +21% | +$29.9K | 0.02% | 689 |
|
|
2015
Q2 | $167K | Sell |
2,661
-753
| -22% | -$47.3K | 0.01% | 732 |
|
|
2015
Q1 | $164K | Buy |
3,414
+1,378
| +68% | +$66.2K | 0.01% | 737 |
|
|
2014
Q4 | $68K | Buy |
+2,036
| New | +$68K | 0.01% | 912 |
|
|
2014
Q3 | – | Sell |
-10,695
| Closed | -$416K | – | 1167 |
|
|
2014
Q2 | $416K | Sell |
10,695
-321
| -3% | -$12.5K | 0.03% | 563 |
|
|
2014
Q1 | $462K | Buy |
11,016
+9,658
| +711% | +$405K | 0.03% | 619 |
|
|
2013
Q4 | $45K | Buy |
1,358
+595
| +78% | +$19.7K | ﹤0.01% | 991 |
|
|
2013
Q3 | $21K | Buy |
+763
| New | +$21K | ﹤0.01% | 1085 |
|